AI Detects Pancreatic Cancer Signs Prior to Tumor Development

A research team at Mayo Clinic has developed an artificial intelligence system that can spot warning signs of pancreatic cancer 3 years before a formal diagnosis is made. The findings, published this week in the journal Gut, suggest the technology could help doctors identify the disease far earlier than is currently possible. 

To build the system, researchers trained the algorithm using CT scans of patients who had undergone imaging for different health complaints but were later found to have pancreatic cancer. The model learned to recognize subtle patterns that might indicate early disease. Its performance was then compared with that of experienced radiologists reviewing the same scans. 

According to the study, the AI tool was about three times more effective at detecting early abnormalities. 

The study’s author and radiologist Dr. Ajit Goenka said the idea was rooted in the biological attributes of the illness. He explained that pancreatic cancer develops over time rather than appearing suddenly, meaning early signals should exist. The challenge has been identifying those signals before the disease becomes advanced. 

Pancreatic cancer is one of the most lethal types of cancer, with a 5-year survival at just 13%. Health experts project it could grow into the second main cause of cancer-linked fatalities by 2030. Roughly four out of five patients are diagnosed after the malignancy has progressed significantly. 

Unlike colon or breast cancer, there isn’t a standard test for screening people without symptoms. The organ is located deep within the abdomen, making physical examination ineffective. Early symptoms are often vague or absent, and more noticeable signs, such as abdominal discomfort or unexplained weight loss, tend to manifest only after the malignancy has spread. 

Radiologists say early-stage tumors are difficult to identify because they do not always form clearly visible masses. Doctors typically look for defined growths on scans, which means cancers often need time to enlarge before they can be seen. 

The artificial intelligence model appears to detect more subtle biological changes, including clusters of abnormal cells that may shield tumors from the immune system. While scientists have long known about these cells, they have been hard to pinpoint using standard imaging. 

Researchers believe the tool could eventually be used to monitor people at higher risk, such as those with a family history of the disease or conditions like diabetes. In such cases, suspicious findings could lead to further testing, including blood analysis or additional imaging. 

Health experts say earlier detection could significantly expand treatment options. Catching the disease before it spreads may allow more patients to undergo surgery or receive therapies that are more effective in early stages. 

Despite the promise, Goenka emphasized that widespread use of the new model is still some years away. Ongoing clinical trials will track participants over several years to confirm how accurately the system predicts future cancer cases. 

Meanwhile, AI is increasingly being studied across medicine as a diagnostic aid. Separate research published in Science found that AI systems can match or even surpass physicians in certain emergency room diagnoses. 

As more advanced technologies are made available by entities like D-Wave Quantum Inc. (NYSE: QBTS), the field of medical radiology could be transformed significantly. 

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN